Προωθημένο
Sun Pharma elevates Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairman
Δημοσιευμένα
Sun Pharma's India business head, Kirti Ganorkar, will become the managing director on September 1, succeeding founder Dilip Shanghvi. Shanghvi will transition to executive chairman, while his son Aalok will oversee North America as COO. Richard Ascroft will take over as CEO of North America, replacing Abhay Gandhi, as Sun Pharma continues its strategic leadership evolution.
Αναζήτηση
Κατηγορίες
- National
- International
- Business
- Technology
- Health
- Εκπαίδευση
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Διαβάζω περισσότερα
Bipin Joshi’s mother and sister leaving for Israel
KATHMANDU: The mother and sister of Bipin Joshi, a Nepali national abducted by the Palestinian...
Nestle India’s maiden 1:1 bonus issue today: FMCG firm eyes enhanced stock liquidity, improved affordability for retail investors— What shareholders should know
Nestle India has set August 8 as the record date for its first-ever 1:1 bonus share issue, a move...
Oman Air, in partnership with TUI launches 'Oman Air Holidays' offering travel packages in 20+ destinations
Oman Air, in collaboration with TUI, has launched 'Oman Air Holidays,' a digital platform...
ICE lifts age cap: Agency to hire 10,000 new applicants; local sheriffs alarmed
US Immigration and Customs Enforcement has eliminated its age limit for deportation agent...